An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine

✍ Scribed by Robert T Schoen; Terry Deshefy-Longhi; Christian Van-Hoecke; Charles Buscarino; Erol Fikrig

• Book ID: 117321528
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 816 KB
• Volume: 25
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/s0149-2918(03)90027-0